Technical Analysis for ELDN - Eledon Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
B 2.82 -2.42% -0.07
ELDN closed down 2.42 percent on Friday, May 24, 2024, on 85 percent of normal volume. The price action carved out a bullish hammer (or hammer-like) candlestick pattern. That may indicate an upside reversal. Look for price to trade above the high of the hammer for confirmation.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Up

Date Alert Name Type % Chg
Hammer Candlestick Bullish 0.00%
Wide Bands Range Expansion 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Inside Day Range Contraction -2.42%
Wide Bands Range Expansion -2.42%
Down 3 Days in a Row Weakness -2.42%
Upper Bollinger Band Walk Strength -5.69%
Wide Bands Range Expansion -5.69%
Overbought Stochastic Strength -5.69%

   Recent Intraday Alerts

Alert Time
60 Minute Opening Range Breakdown 4 days ago
Down 10% 4 days ago
Down 1 ATR 4 days ago
Down 5% 4 days ago
Down 3% 4 days ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Eledon Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing products for patients with disorders of ear, nose, and throat. The company's lead product is OP0201, a surfactant-based nasal aerosol drug-device combination product for patients at risk for, or with, otitis media (OM) (middle ear inflammation with or without infection). It also has a foam-based drug delivery technology OP0101 and OP0102 that could be used to deliver drugs into the ear, nose, and sinus cavities. The company was formerly known as Novus Therapeutics, Inc. and changed its name to Eledon Pharmaceuticals, Inc. in January 2021. Eledon Pharmaceuticals, Inc. is headquartered in Irvine, California.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Pharmaceutical Health Sciences Medication Infection Disorders Sinus Audiology Pediatrics Otorhinolaryngology Pernix Therapeutics Holdings

Is ELDN a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 3.349
52 Week Low 1.07
Average Volume 222,930
200-Day Moving Average 1.66
50-Day Moving Average 2.13
20-Day Moving Average 2.57
10-Day Moving Average 2.78
Average True Range 0.27
RSI (14) 61.24
ADX 24.08
+DI 27.15
-DI 22.83
Chandelier Exit (Long, 3 ATRs) 2.55
Chandelier Exit (Short, 3 ATRs) 2.71
Upper Bollinger Bands 3.18
Lower Bollinger Band 1.96
Percent B (%b) 0.71
BandWidth 47.31
MACD Line 0.25
MACD Signal Line 0.22
MACD Histogram 0.0268
Fundamentals Value
Market Cap 68.24 Million
Num Shares 24.2 Million
EPS -5.44
Price-to-Earnings (P/E) Ratio -0.52
Price-to-Sales 0.00
Price-to-Book 0.45
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.30
Resistance 3 (R3) 3.27 3.08 3.22
Resistance 2 (R2) 3.08 2.96 3.10 3.19
Resistance 1 (R1) 2.95 2.88 2.86 2.98 3.17
Pivot Point 2.76 2.76 2.71 2.78 2.76
Support 1 (S1) 2.63 2.64 2.54 2.66 2.47
Support 2 (S2) 2.44 2.56 2.46 2.45
Support 3 (S3) 2.31 2.44 2.42
Support 4 (S4) 2.34